MedTrace Logo

MK0954A-264 Filter Study (0954A-264)(COMPLETED)

NCT00307060 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 274

Last updated 2024-08-15

No results posted yet for this study

Summary

To compare the blood pressure lowering efficacy, safety and tolerability of a combination drug to a single drug taken once daily in patients with uncontrolled blood pressure following a 4-week filter on the single therapy product.

Conditions

  • Mild to Severe Hypertension

Interventions

DRUG

MK0954A, hydrochlorothiazide (+) losartan potassium / Duration of Treatment: 6 weeks

DRUG

losartan / Duration of Treatment: 6 weeks

Sponsors & Collaborators

  • Organon and Co

    lead INDUSTRY

Principal Investigators

  • Medical Monitor · Merck Sharp & Dohme LLC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-12-01
Primary Completion
2005-06-01
Completion
2005-06-02

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00307060 on ClinicalTrials.gov